Veerle Mh Coupé

16PUBLICATIONS
106CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 14, 2026
Personalized risk estimates of advanced neoplasia development in individuals with a family history of colorectal cancer.

|Nov 10, 2025
CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness.

Haoyue Wang, Astrid Kramer, Marjolein J E Greuter

|Jul 09, 2025
Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors.

Zakile A Mfumbilwa, Janneke A Wilschut, Harry J M Groen

|Mar 29, 2024
Polyketide synthase positive Escherichia coli one-time measurement in stool is not informative of colorectal cancer risk in a screening setting.

Willemijn de Klaver, Meike de Wit, Anne Bolijn

|Feb 16, 2024
Cumulative Incidence, Risk Factors, and Overall Survival of Disease Recurrence after Curative Resection of Stage II-III Colorectal Cancer: A Population-based Study.

Tara C Boute, Hidde Swartjes, Marjolein J E Greuter

|Jan 09, 2024
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy.

Pageof 3

Frequent Collaborators

6 joint publications

Marjolein J E Greuter

5 joint publications

Zakile A Mfumbilwa

4 joint publications

Valesca Retèl

4 joint publications

Bram Ramaekers